Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-03-09

Clinical Trial Update: Oxygen Therapy for Retinal Ischemia [Phase 4]

View source ↗

Summary

Phase 4 trial investigating oxygen therapy for retinal ischemia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Retinal Ischemia | Phase 4 | Status: WITHDRAWN